- Home
- ATOS vs ABLV Comparison
ATOS vs ABLV Comparison
Compare ATOS & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATOS | ABLV |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | China |
| Employees | N/A | 89 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2M | 36.5M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATOS | ABLV |
|---|---|---|
| Price | $5.43 | $0.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 53.0K | ★ 398.2K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.54 |
| 52 Week High | $7.56 | $1.77 |
Technical Indicators
Market Signals| Indicator | ATOS | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 51.71 |
| Support Level | $0.66 | $0.60 |
| Resistance Level | $5.56 | $0.93 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 50.32 | 42.74 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.